Use of the receptor GPR86
We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which t...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SOPHIE MESSAGER NICOLA BRICE JOHN DIXON DIRK ZAHN MARK CARLTON ISABELLE MALINGE ALAN HENDRICK |
description | We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2005258934A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2005258934A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2005258934A13</originalsourceid><addsrcrecordid>eNrjZJAMLU5VyE9TKMlIVShKTU4tKMkvUnAPCLIw42FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGpkamFpbGJo6GxsSpAgA0ACJa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use of the receptor GPR86</title><source>esp@cenet</source><creator>SOPHIE MESSAGER ; NICOLA BRICE ; JOHN DIXON ; DIRK ZAHN ; MARK CARLTON ; ISABELLE MALINGE ; ALAN HENDRICK</creator><creatorcontrib>SOPHIE MESSAGER ; NICOLA BRICE ; JOHN DIXON ; DIRK ZAHN ; MARK CARLTON ; ISABELLE MALINGE ; ALAN HENDRICK</creatorcontrib><description>We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto.</description><language>eng</language><subject>CHEMISTRY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; TESTING</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060112&DB=EPODOC&CC=AU&NR=2005258934A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060112&DB=EPODOC&CC=AU&NR=2005258934A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SOPHIE MESSAGER</creatorcontrib><creatorcontrib>NICOLA BRICE</creatorcontrib><creatorcontrib>JOHN DIXON</creatorcontrib><creatorcontrib>DIRK ZAHN</creatorcontrib><creatorcontrib>MARK CARLTON</creatorcontrib><creatorcontrib>ISABELLE MALINGE</creatorcontrib><creatorcontrib>ALAN HENDRICK</creatorcontrib><title>Use of the receptor GPR86</title><description>We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto.</description><subject>CHEMISTRY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAMLU5VyE9TKMlIVShKTU4tKMkvUnAPCLIw42FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGpkamFpbGJo6GxsSpAgA0ACJa</recordid><startdate>20060112</startdate><enddate>20060112</enddate><creator>SOPHIE MESSAGER</creator><creator>NICOLA BRICE</creator><creator>JOHN DIXON</creator><creator>DIRK ZAHN</creator><creator>MARK CARLTON</creator><creator>ISABELLE MALINGE</creator><creator>ALAN HENDRICK</creator><scope>EVB</scope></search><sort><creationdate>20060112</creationdate><title>Use of the receptor GPR86</title><author>SOPHIE MESSAGER ; NICOLA BRICE ; JOHN DIXON ; DIRK ZAHN ; MARK CARLTON ; ISABELLE MALINGE ; ALAN HENDRICK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2005258934A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>SOPHIE MESSAGER</creatorcontrib><creatorcontrib>NICOLA BRICE</creatorcontrib><creatorcontrib>JOHN DIXON</creatorcontrib><creatorcontrib>DIRK ZAHN</creatorcontrib><creatorcontrib>MARK CARLTON</creatorcontrib><creatorcontrib>ISABELLE MALINGE</creatorcontrib><creatorcontrib>ALAN HENDRICK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SOPHIE MESSAGER</au><au>NICOLA BRICE</au><au>JOHN DIXON</au><au>DIRK ZAHN</au><au>MARK CARLTON</au><au>ISABELLE MALINGE</au><au>ALAN HENDRICK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use of the receptor GPR86</title><date>2006-01-12</date><risdate>2006</risdate><abstract>We describe a method of identifying a molecule suitable for the treatment, prophylaxis or alleviation of a GPR86 associated disease, in particular inflammatory disease or pain, the method comprising determining whether a candidate molecule is an agonist or antagonist of GPR86 polypeptide, in which the GPR86 polypeptide comprises the amino acid sequence shown in SEQ ID NO: 3 or SEQ ID NO: 5 or SEQ ID NO: 7, a fragment thereof or a sequence which is at least 90% identical thereto.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2005258934A1 |
source | esp@cenet |
subjects | CHEMISTRY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS TESTING |
title | Use of the receptor GPR86 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T09%3A47%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SOPHIE%20MESSAGER&rft.date=2006-01-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2005258934A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |